Filing Details
- Accession Number:
- 0000950170-25-071661
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-14 17:51:17
- Reporting Period:
- 2025-05-12
- Filing Date:
- 2025-05-14
- Accepted Time:
- 2025-05-14 17:51:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1088856 | Corcept Therapeutics Inc | CORT | Pharmaceutical Preparations (2834) | 770487658 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1323113 | Jr N Daniel Swisher | C/O Corcept Therapeutics Incorporated 101 Redwood Shores Parkway Redwood City CA 94065 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-05-12 | 1,800 | $12.13 | 1,800 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2025-05-12 | 400 | $14.08 | 2,200 | No | 4 | M | Direct | |
Common Stock | Disposition | 2025-05-12 | 1,800 | $72.17 | 400 | No | 4 | S | Direct | |
Common Stock | Disposition | 2025-05-12 | 400 | $71.55 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock option (right to buy) | Disposition | 2025-05-12 | 1,800 | $0.00 | 1,800 | $12.13 |
Common Stock | Stock option (right to buy) | Disposition | 2025-05-12 | 400 | $0.00 | 400 | $14.08 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2027-05-24 | No | 4 | M | Direct | |
12,100 | 2028-08-20 | No | 4 | M | Direct |
Footnotes
- The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on August 1, 2024 in effect at the time of this transaction.
- Fully exercisable.
- The Reporting Person previously transferred 12,500 shares underlying the stock option to his ex-spouse. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse.